Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: results of two phase II cytokine working group …

LE Flaherty, M Atkins, J Sosman, G Weiss… - Journal of clinical …, 2001 - ascopubs.org
PURPOSE: The Cytokine Working Group performed a randomized phase II trial of two
outpatient biochemotherapy regimens to identify an outpatient regimen with high antitumor …
被引用次数：67 相关文章

[引用][C] Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: results of two phase II Cytokine Working …

LE FLAHERTY, M ATKINS, P SOROKIN… - Journal of clinical …, 2001 - pascal-francis.inist.fr
Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic
malignant melanoma: results of two phase II Cytokine Working Group trials CNRS Inist …

Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: results of two phase II cytokine working group …

LE Flaherty, M Atkins, J Sosman… - Journal of clinical …, 2001 - pubmed.ncbi.nlm.nih.gov
Purpose The Cytokine Working Group performed a randomized phase II trial of two
outpatient biochemotherapy regimens to identify an outpatient regimen with high antitumor …

Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: Results of two phase II Cytokine Working Group …

LE Flaherty, M Atkins, J Sosman… - Journal of …, 2001 - providence.elsevierpure.com
Purpose: The Cytokine Working Group performed a randomized phase II trial of two
outpatient biochemotherapy regimens to identify an outpatient regimen with high antitumor …

Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: Results of two phase II Cytokine Working Group …

LE Flaherty, M Atkins, J Sosman… - Journal of Clinical …, 2001 - scholars.northwestern.edu
Purpose: The Cytokine Working Group performed a randomized phase II trial of two
outpatient biochemotherapy regimens to identify an outpatient regimen with high antitumor …

Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: results of two phase II cytokine working group …

LE Flaherty, M Atkins, J Sosman, G Weiss… - Journal of Clinical …, 2001 - europepmc.org
Purpose The Cytokine Working Group performed a randomized phase II trial of two
outpatient biochemotherapy regimens to identify an outpatient regimen with high antitumor …

[引用][C] Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: results of two phase II Cytokine Working …

LE FLAHERTY, M ATKINS… - Journal of …, 2001 - American Society of Clinical …